| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.19e-06 | 31 | 158 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.06e-05 | 18 | 158 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium channel activity | 7.58e-05 | 129 | 158 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.29e-04 | 33 | 158 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | diglucosylglycerate octanoyltransferase activity | 1.86e-04 | 3 | 158 | 2 | GO:0016414 | |
| GeneOntologyMolecularFunction | carnitine O-octanoyltransferase activity | 1.86e-04 | 3 | 158 | 2 | GO:0008458 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.02e-04 | 151 | 158 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB2 TRPV1 TTYH2 GRIN2A PANX3 RYR1 RYR3 ITPR3 BSND PIEZO2 SCN2A SEC61A1 | 3.01e-04 | 459 | 158 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.69e-04 | 4 | 158 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 4.86e-04 | 82 | 158 | 5 | GO:1990756 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 8.83e-04 | 193 | 158 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | carnitine O-acyltransferase activity | 9.14e-04 | 6 | 158 | 2 | GO:0016406 | |
| GeneOntologyMolecularFunction | alkaline phosphatase activity | 9.14e-04 | 6 | 158 | 2 | GO:0004035 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 9.14e-04 | 6 | 158 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 9.40e-04 | 55 | 158 | 4 | GO:0042974 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 9.51e-04 | 95 | 158 | 5 | GO:0140767 | |
| GeneOntologyMolecularFunction | channel activity | GABRB2 TRPV1 TTYH2 GRIN2A PANX3 RYR1 RYR3 ITPR3 BSND PIEZO2 SCN2A SEC61A1 | 9.84e-04 | 525 | 158 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 9.95e-04 | 197 | 158 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB2 TRPV1 TTYH2 GRIN2A PANX3 RYR1 RYR3 ITPR3 BSND PIEZO2 SCN2A SEC61A1 | 1.00e-03 | 526 | 158 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | gated channel activity | 1.40e-03 | 334 | 158 | 9 | GO:0022836 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.73e-05 | 42 | 159 | 5 | GO:0099560 | |
| GeneOntologyBiologicalProcess | synapse assembly | GABRB2 NRG1 PDGFB USP9X PCLO MAGI2 DOCK7 ADGRL2 MDGA1 CDH9 ADGRL3 | 2.81e-05 | 308 | 159 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | response to nutrient levels | CYP1A1 TRPV1 DSC2 PARP2 LRRK2 F5 FBXO22 GCLC SCD AGL CPEB4 NPRL3 BCL10 ULK1 MLST8 | 3.36e-05 | 566 | 159 | 15 | GO:0031667 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 2.92e-05 | 47 | 160 | 5 | GO:0031462 | |
| GeneOntologyCellularComponent | Z disc | 1.66e-04 | 151 | 160 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK2 FLNB TRPV1 PDGFB FAT3 PCLO LRRK2 CNTNAP3 MPDZ GRIN2A DCTN1 ITPR3 MAGI2 SNCAIP FCGR2B CPEB4 ULK1 ARHGEF2 MDGA1 NOS1 CDH9 EPHA8 | 1.74e-04 | 1228 | 160 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | myofibril | 2.62e-04 | 273 | 160 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | I band | 2.96e-04 | 166 | 160 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | dendrite | PCSK2 TRPV1 PDGFB FAT3 PCLO LRRK2 MPDZ GRIN2A ITPR3 MAGI2 FCGR2B CPEB4 ARHGEF2 MDGA1 NOS1 CDH9 EPHA8 | 3.21e-04 | 858 | 160 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | PCSK2 TRPV1 PDGFB FAT3 PCLO LRRK2 MPDZ GRIN2A ITPR3 MAGI2 FCGR2B CPEB4 ARHGEF2 MDGA1 NOS1 CDH9 EPHA8 | 3.29e-04 | 860 | 160 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.08e-04 | 290 | 160 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | Sec61 translocon complex | 5.73e-04 | 5 | 160 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.80e-04 | 88 | 160 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | translocon complex | 8.56e-04 | 6 | 160 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | axon | NRG1 USP9X PCLO LRRK2 CNTNAP3 EXOC3 GRIN2A DCTN1 SCN2A CPEB4 DOCK7 ULK1 MDGA1 NOS1 CDH9 ADGRL3 | 1.37e-03 | 891 | 160 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | secretory vesicle | PCSK2 ABCC4 KLK6 ANPEP PDGFB ACR PRAMEF15 LRRK2 EXOC3 GRIN2A PRAMEF4 F5 ITPR3 CFD SNCAIP AGL KLK1 NOS1 PRAMEF11 VEGFB | 1.37e-03 | 1246 | 160 | 20 | GO:0099503 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.67e-03 | 164 | 160 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.74e-03 | 67 | 160 | 4 | GO:0031093 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.85e-03 | 114 | 160 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | secretory granule | PCSK2 ABCC4 KLK6 ANPEP PDGFB ACR PRAMEF15 EXOC3 PRAMEF4 F5 ITPR3 CFD AGL KLK1 NOS1 PRAMEF11 VEGFB | 2.01e-03 | 1014 | 160 | 17 | GO:0030141 |
| GeneOntologyCellularComponent | junctional membrane complex | 2.02e-03 | 9 | 160 | 2 | GO:0030314 | |
| Domain | RIH_assoc-dom | 1.06e-05 | 6 | 153 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.06e-05 | 6 | 153 | 3 | PF08709 | |
| Domain | RIH_assoc | 1.06e-05 | 6 | 153 | 3 | PF08454 | |
| Domain | RIH_dom | 1.06e-05 | 6 | 153 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.06e-05 | 6 | 153 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.06e-05 | 6 | 153 | 3 | IPR015925 | |
| Domain | - | 1.06e-05 | 6 | 153 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.06e-05 | 6 | 153 | 3 | PF01365 | |
| Domain | PRAME_family | 1.52e-05 | 19 | 153 | 4 | IPR026271 | |
| Domain | Cadherin_C | 4.79e-05 | 25 | 153 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 4.79e-05 | 25 | 153 | 4 | IPR000233 | |
| Domain | MIR | 6.20e-05 | 10 | 153 | 3 | PF02815 | |
| Domain | MIR_motif | 6.20e-05 | 10 | 153 | 3 | IPR016093 | |
| Domain | MIR | 6.20e-05 | 10 | 153 | 3 | PS50919 | |
| Domain | MIR | 6.20e-05 | 10 | 153 | 3 | SM00472 | |
| Domain | SecY_su_dom | 6.67e-05 | 2 | 153 | 2 | IPR023201 | |
| Domain | SECY_1 | 6.67e-05 | 2 | 153 | 2 | PS00755 | |
| Domain | SECY_2 | 6.67e-05 | 2 | 153 | 2 | PS00756 | |
| Domain | - | 6.67e-05 | 2 | 153 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 6.67e-05 | 2 | 153 | 2 | IPR019561 | |
| Domain | SecY_CS | 6.67e-05 | 2 | 153 | 2 | IPR030659 | |
| Domain | Plug_translocon | 6.67e-05 | 2 | 153 | 2 | PF10559 | |
| Domain | SecY | 6.67e-05 | 2 | 153 | 2 | PF00344 | |
| Domain | SecY/SEC61-alpha | 6.67e-05 | 2 | 153 | 2 | IPR002208 | |
| Domain | Catenin_binding_dom | 8.77e-05 | 29 | 153 | 4 | IPR027397 | |
| Domain | - | 8.77e-05 | 29 | 153 | 4 | 4.10.900.10 | |
| Domain | Galactose-bd-like | 1.23e-04 | 94 | 153 | 6 | IPR008979 | |
| Domain | Latrophilin | 1.99e-04 | 3 | 153 | 2 | PF02354 | |
| Domain | Ryanodine_rcpt | 1.99e-04 | 3 | 153 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.99e-04 | 3 | 153 | 2 | IPR009460 | |
| Domain | RyR | 1.99e-04 | 3 | 153 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.99e-04 | 3 | 153 | 2 | PF06459 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 1.99e-04 | 3 | 153 | 2 | IPR003334 | |
| Domain | Ryan_recept | 1.99e-04 | 3 | 153 | 2 | IPR013333 | |
| Domain | Nebulin | 3.96e-04 | 4 | 153 | 2 | PF00880 | |
| Domain | Alk_phosphatase | 3.96e-04 | 4 | 153 | 2 | PF00245 | |
| Domain | Alkaline_phosphatase_AS | 3.96e-04 | 4 | 153 | 2 | IPR018299 | |
| Domain | NEBULIN | 3.96e-04 | 4 | 153 | 2 | PS51216 | |
| Domain | NEBU | 3.96e-04 | 4 | 153 | 2 | SM00227 | |
| Domain | Nebulin | 3.96e-04 | 4 | 153 | 2 | IPR013998 | |
| Domain | Alkaline_phosphatase | 3.96e-04 | 4 | 153 | 2 | IPR001952 | |
| Domain | Nebulin_repeat | 3.96e-04 | 4 | 153 | 2 | IPR000900 | |
| Domain | alkPPc | 3.96e-04 | 4 | 153 | 2 | SM00098 | |
| Domain | ALKALINE_PHOSPHATASE | 3.96e-04 | 4 | 153 | 2 | PS00123 | |
| Domain | Gal_Lectin | 6.56e-04 | 5 | 153 | 2 | PF02140 | |
| Domain | INTEGRASE | 6.56e-04 | 5 | 153 | 2 | PS50994 | |
| Domain | Integrase_cat-core | 6.56e-04 | 5 | 153 | 2 | IPR001584 | |
| Domain | GPCR_2_latrophilin | 6.56e-04 | 5 | 153 | 2 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 6.56e-04 | 5 | 153 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 6.56e-04 | 5 | 153 | 2 | PS50228 | |
| Domain | Carn_acyl_trans | 1.36e-03 | 7 | 153 | 2 | IPR000542 | |
| Domain | Desmosomal_cadherin | 1.36e-03 | 7 | 153 | 2 | IPR009122 | |
| Domain | Cadherin_pro | 1.36e-03 | 7 | 153 | 2 | PF08758 | |
| Domain | Carn_acyltransf | 1.36e-03 | 7 | 153 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 1.36e-03 | 7 | 153 | 2 | PS00439 | |
| Domain | PD_growth_factor_CS | 1.36e-03 | 7 | 153 | 2 | IPR023581 | |
| Domain | ACYLTRANSF_C_2 | 1.36e-03 | 7 | 153 | 2 | PS00440 | |
| Domain | Cadherin_pro | 1.81e-03 | 8 | 153 | 2 | SM01055 | |
| Domain | Cadherin_pro_dom | 1.81e-03 | 8 | 153 | 2 | IPR014868 | |
| Domain | Cadherin_CS | 2.04e-03 | 109 | 153 | 5 | IPR020894 | |
| Domain | BEACH | 2.31e-03 | 9 | 153 | 2 | PS50197 | |
| Domain | Beach | 2.31e-03 | 9 | 153 | 2 | PF02138 | |
| Domain | - | 2.31e-03 | 9 | 153 | 2 | 1.10.1540.10 | |
| Domain | PDGF_1 | 2.31e-03 | 9 | 153 | 2 | PS00249 | |
| Domain | Beach | 2.31e-03 | 9 | 153 | 2 | SM01026 | |
| Domain | PDGF | 2.31e-03 | 9 | 153 | 2 | SM00141 | |
| Domain | BEACH_dom | 2.31e-03 | 9 | 153 | 2 | IPR000409 | |
| Domain | PDGF | 2.31e-03 | 9 | 153 | 2 | PF00341 | |
| Domain | PDGF_2 | 2.31e-03 | 9 | 153 | 2 | PS50278 | |
| Domain | PDGF/VEGF_dom | 2.31e-03 | 9 | 153 | 2 | IPR000072 | |
| Domain | CADHERIN_1 | 2.39e-03 | 113 | 153 | 5 | PS00232 | |
| Domain | Cadherin | 2.39e-03 | 113 | 153 | 5 | PF00028 | |
| Domain | Ion_trans_dom | 2.48e-03 | 114 | 153 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.48e-03 | 114 | 153 | 5 | PF00520 | |
| Domain | CADHERIN_2 | 2.48e-03 | 114 | 153 | 5 | PS50268 | |
| Domain | - | 2.48e-03 | 114 | 153 | 5 | 2.60.40.60 | |
| Domain | CA | 2.57e-03 | 115 | 153 | 5 | SM00112 | |
| Domain | Cadherin-like | 2.67e-03 | 116 | 153 | 5 | IPR015919 | |
| Domain | Cadherin | 2.88e-03 | 118 | 153 | 5 | IPR002126 | |
| Domain | - | 3.04e-03 | 73 | 153 | 4 | 2.60.120.260 | |
| Domain | GAIN_dom_N | 3.49e-03 | 11 | 153 | 2 | IPR032471 | |
| Domain | GAIN | 3.49e-03 | 11 | 153 | 2 | PF16489 | |
| Domain | Oxysterol-bd_CS | 4.17e-03 | 12 | 153 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 4.17e-03 | 12 | 153 | 2 | PF01237 | |
| Domain | Oxysterol-bd | 4.17e-03 | 12 | 153 | 2 | IPR000648 | |
| Domain | OSBP | 4.17e-03 | 12 | 153 | 2 | PS01013 | |
| Domain | OLF | 4.90e-03 | 13 | 153 | 2 | PF02191 | |
| Domain | OLF | 4.90e-03 | 13 | 153 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 4.90e-03 | 13 | 153 | 2 | IPR003112 | |
| Domain | OLF | 4.90e-03 | 13 | 153 | 2 | SM00284 | |
| Domain | TRYPSIN_SER | 6.41e-03 | 90 | 153 | 4 | IPR033116 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 22100703 | ||
| Pubmed | HDAC9 MAN2B2 PTPN23 WDFY4 SLC45A4 FAN1 PER3 ALMS1 OSBPL3 N4BP2 CPEB4 WDR35 PRDM16 | 5.67e-07 | 493 | 161 | 13 | 15368895 | |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 22438068 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.93e-06 | 6 | 161 | 3 | 25966694 | |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.93e-06 | 6 | 161 | 3 | 16844763 | |
| Pubmed | 2.02e-06 | 20 | 161 | 4 | 26694250 | ||
| Pubmed | 3.03e-06 | 22 | 161 | 4 | 31729367 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 11860456 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 4.32e-06 | 91 | 161 | 6 | 28558017 | |
| Pubmed | 5.19e-06 | 25 | 161 | 4 | 37451217 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 5.36e-06 | 8 | 161 | 3 | 19033399 | |
| Pubmed | RALGAPA1 IRS4 USP9X MPDZ NCKAP5L LRCH1 ALMS1 NYNRIN CPEB4 DOCK7 ARHGEF2 | 8.11e-06 | 446 | 161 | 11 | 24255178 | |
| Pubmed | 8.31e-06 | 28 | 161 | 4 | 25089626 | ||
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 1.04e-05 | 62 | 161 | 5 | 26508657 | |
| Pubmed | 1.56e-05 | 11 | 161 | 3 | 33558705 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | KLK6 MAN2B2 DSC2 NEBL PRAMEF15 GRIN2A IDE PRAMEF4 SULT1C4 OGDH DCTN1 ADAR MAGI2 GCLC OSBPL3 PLXNA2 PRAMEF11 DNPEP | 1.96e-05 | 1242 | 161 | 18 | 30973865 |
| Pubmed | 2.07e-05 | 35 | 161 | 4 | 19389355 | ||
| Pubmed | Purification and partial sequencing of human placental alkaline phosphatase. | 2.13e-05 | 2 | 161 | 2 | 6651840 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21371516 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 25301747 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22342962 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9489997 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 2.13e-05 | 2 | 161 | 2 | 12640042 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11124260 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 3461452 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 3459156 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 1730777 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 14592949 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 33509238 | ||
| Pubmed | LRRK2 expression is enriched in the striosomal compartment of mouse striatum. | 2.13e-05 | 2 | 161 | 2 | 22850484 | |
| Pubmed | Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. | 2.13e-05 | 2 | 161 | 2 | 3001717 | |
| Pubmed | Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins. | 2.13e-05 | 2 | 161 | 2 | 30792275 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22589245 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9799464 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 3042787 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16959869 | ||
| Pubmed | Substrate specificity of human kallikreins 1 and 6 determined by phage display. | 2.13e-05 | 2 | 161 | 2 | 18359858 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 33646123 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19851499 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 2.13e-05 | 2 | 161 | 2 | 17118445 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21949864 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 3422741 | ||
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 2.13e-05 | 2 | 161 | 2 | 11500519 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23202294 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 26811536 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18480044 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 1939159 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23936174 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12565913 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9192302 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 36077054 | ||
| Pubmed | ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. | 2.13e-05 | 2 | 161 | 2 | 37208334 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 7556644 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 2153284 | ||
| Pubmed | 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening. | 2.13e-05 | 2 | 161 | 2 | 26546614 | |
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 2.13e-05 | 2 | 161 | 2 | 15894801 | |
| Pubmed | Molecular cloning and sequence analysis of human placental alkaline phosphatase. | 2.13e-05 | 2 | 161 | 2 | 3512548 | |
| Pubmed | ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression. | 2.13e-05 | 2 | 161 | 2 | 27023913 | |
| Pubmed | Common allosteric mechanisms between ryanodine and inositol-1,4,5-trisphosphate receptors. | 2.13e-05 | 2 | 161 | 2 | 21150295 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9817784 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 38520674 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 15327990 | ||
| Pubmed | RALGAPA1 PITHD1 FLNB RIOK1 DSC2 DSC3 USP9X EXOC3 MPDZ PTPN23 MCM4 DOCK7 ADGRL2 | 2.80e-05 | 708 | 161 | 13 | 39231216 | |
| Pubmed | 3.41e-05 | 14 | 161 | 3 | 36639541 | ||
| Pubmed | ZCCHC12 PEG10 PRAMEF15 KHDRBS2 PRAMEF4 ADAR SUPT6H CPEB4 PRAMEF11 | 3.73e-05 | 347 | 161 | 9 | 16033648 | |
| Pubmed | RALGAPA1 FLNB USP9X PCLO SCRN1 GRIN2A OGDH DCTN1 MAGI2 NWD2 SUGP2 SCN2A CPEB4 DOCK7 OSBPL10 PACS2 ARHGEF2 NOS1 DNPEP | 3.77e-05 | 1431 | 161 | 19 | 37142655 | |
| Pubmed | FLNB IRS4 UNCX PCLO KHDRBS2 NUCB1 CCDC150 NEB OGDH DCTN1 AAR2 SEC61A2 GCLC N4BP2 ULK1 ARHGEF2 PPIP5K2 SEC61A1 PLXNA2 | 4.17e-05 | 1442 | 161 | 19 | 35575683 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNB BMS1 MCC MPDZ PTPN23 MCM4 IDE NCKAP5L AAR2 ITPR3 FBXO22 OSBPL3 AGL ADGRL2 SEC61A1 | 5.09e-05 | 974 | 161 | 15 | 28675297 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 IRS4 DSC2 MPDZ NCKAP5L DNAH7 ALMS1 SAMD11 OSBPL3 N4BP2 DOCK7 OSBPL10 ARHGEF2 PPIP5K2 | 5.14e-05 | 861 | 161 | 14 | 36931259 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.28e-05 | 363 | 161 | 9 | 14691545 | |
| Pubmed | 6.20e-05 | 46 | 161 | 4 | 17287250 | ||
| Pubmed | RALGAPA1 DSC2 DSC3 PEG10 NUCB1 BMS1 EXOC3 MPDZ NCKAP5L OGDH DCTN1 AAR2 ITPR3 SEC61A2 SUPT6H SCD N4BP2 ADGRL2 SEC61A1 | 6.28e-05 | 1487 | 161 | 19 | 33957083 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 6.31e-05 | 17 | 161 | 3 | 23565261 | |
| Pubmed | 6.31e-05 | 17 | 161 | 3 | 37781892 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 10994649 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 18403125 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 11171121 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 37735974 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 16973277 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 7876312 | ||
| Pubmed | The Gag protein PEG10 binds to RNA and regulates trophoblast stem cell lineage specification. | 6.37e-05 | 3 | 161 | 2 | 30951545 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 21862590 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 30914440 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 24652679 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 6102994 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 6.37e-05 | 3 | 161 | 2 | 10788707 | |
| Pubmed | Organic pyrophosphates as substrates for human alkaline phosphatases. | 6.37e-05 | 3 | 161 | 2 | 16742561 | |
| Pubmed | The Circadian Clock Regulates Adipogenesis by a Per3 Crosstalk Pathway to Klf15. | 6.37e-05 | 3 | 161 | 2 | 29186676 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 34825354 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 6.37e-05 | 3 | 161 | 2 | 7621815 | |
| Pubmed | SIRT1 accelerates the progression of activity-based anorexia. | 6.37e-05 | 3 | 161 | 2 | 32499508 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 23975055 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 6.37e-05 | 3 | 161 | 2 | 10473538 | |
| Pubmed | Compositionally different desmosomes in the various compartments of the human hair follicle. | 6.37e-05 | 3 | 161 | 2 | 9810708 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 9389456 | ||
| Pubmed | Assignment of the human genes for desmocollin 3 (DSC3) and desmocollin 4 (DSC4) to chromosome 18q12. | 6.37e-05 | 3 | 161 | 2 | 7774948 | |
| Pubmed | A novel form of capsaicin-modified amygdala LTD mediated by TRPM1. | 6.37e-05 | 3 | 161 | 2 | 27633915 | |
| Cytoband | 1p36.21 | 2.97e-06 | 63 | 161 | 5 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PITHD1 PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 DFFB PER3 SAMD11 PRDM16 PRAMEF27 PRAMEF11 EPHA8 | 5.76e-06 | 681 | 161 | 12 | chr1p36 |
| Cytoband | 14q11.1 | 5.40e-04 | 10 | 161 | 2 | 14q11.1 | |
| Cytoband | 5q21 | 7.88e-04 | 12 | 161 | 2 | 5q21 | |
| Cytoband | 7q21 | 9.29e-04 | 13 | 161 | 2 | 7q21 | |
| GeneFamily | PRAME family | 3.05e-09 | 24 | 100 | 6 | 686 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 9.05e-05 | 3 | 100 | 2 | 287 | |
| GeneFamily | Alkaline phosphatases | 1.80e-04 | 4 | 100 | 2 | 1072 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 1.80e-04 | 4 | 100 | 2 | 918 | |
| GeneFamily | Desmosomal cadherins | 6.25e-04 | 7 | 100 | 2 | 1188 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.06e-03 | 9 | 100 | 2 | 1230 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.93e-03 | 12 | 100 | 2 | 670 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.27e-03 | 13 | 100 | 2 | 1186 | |
| GeneFamily | Kallikreins | 3.46e-03 | 16 | 100 | 2 | 616 | |
| GeneFamily | Aminopeptidases|CD molecules | 3.90e-03 | 17 | 100 | 2 | 104 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DSC2 NEBL ANPEP PEG10 FAT3 MCC MPDZ MCM4 SCRN1 DNAH7 MAGI2 HEY1 SCD NYNRIN SCN2A WDR35 ADGRL2 CDH6 PLXNA2 ADGRL3 DSE MBNL3 | 1.25e-07 | 827 | 153 | 22 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 3.67e-06 | 33 | 153 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | DSC2 ANPEP PEG10 FAT3 MCC MPDZ RNASE12 MAGI2 NYNRIN SCN2A ZSCAN18 WDR35 PPIP5K2 ADGRL2 CDH6 PLXNA2 ADGRL3 MBNL3 CDON | 3.77e-06 | 783 | 153 | 19 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | DSC2 ANPEP PEG10 FAT3 MCC DNAH7 MAGI2 NYNRIN ZSCAN18 KLHL8 PPIP5K2 NOS1 CDH6 PLXNA2 ADGRL3 DSE MBNL3 CDON | 1.82e-05 | 797 | 153 | 18 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100 | 2.46e-05 | 80 | 153 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.72e-05 | 270 | 153 | 10 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DSC2 PEG10 FAT3 MCC MPDZ DNAH7 MAGI2 NYNRIN SCN2A ZSCAN18 WDR35 ADGRL2 CDH6 PLXNA2 ADGRL3 MBNL3 CDON | 1.06e-04 | 831 | 153 | 17 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | DSC2 ANPEP PEG10 MAGI2 NYNRIN SCN2A ADGRL2 CDH6 ADGRL3 MBNL3 CDON | 1.21e-04 | 388 | 153 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | GABRB2 ABCC4 UNCX RNASE12 SCRN1 TMEM52B SNCAIP CCDC198 HEY1 PRDM16 CDH6 | 1.51e-04 | 398 | 153 | 11 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_500 | NEBL UNCX USP9X CYB561D2 TTYH2 SCRN1 TMEM52B CCDC198 HEY1 PRDM16 CDH6 | 1.80e-04 | 406 | 153 | 11 | gudmap_developingKidney_e15.5_S-shaped body_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | DSC2 ANPEP PEG10 FAT3 MCC MAGI2 SNCAIP NYNRIN SCN2A PPIP5K2 ADGRL2 CDH6 PLXNA2 ADGRL3 MBNL3 CDON | 2.12e-04 | 797 | 153 | 16 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500 | 2.20e-04 | 168 | 153 | 7 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.26e-04 | 224 | 153 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | DSC2 NEBL FAT3 MCC SCRN1 NYNRIN SCN2A ADGRL2 CDH6 ADGRL3 MBNL3 | 2.31e-04 | 418 | 153 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | ANPEP LRRK2 WDFY4 GCSAM ALMS1 LPCAT2 FCGR2B GCLC OSBPL3 DOCK7 CDON | 2.66e-04 | 425 | 153 | 11 | GSM538255_500 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.83e-04 | 80 | 153 | 5 | gudmap_kidney_adult_RenMedVasc_Tie2_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.94e-04 | 125 | 153 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | PIK3AP1 NRG1 ABCC4 NEBL ANPEP KHDRBS2 LRRK2 RHEX CCDC198 SLC28A1 OSBPL10 CDH6 CDH9 | 1.64e-13 | 184 | 161 | 13 | 51ed1ebfdef45149541917c66cbacad87072e51f |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NRG1 ABCC4 KHDRBS2 LRRK2 SULT1C4 RHEX SLC28A1 OSBPL10 CDH6 CDH9 | 1.62e-09 | 186 | 161 | 10 | f28d72b47624b69a580b4429e2be560a26898591 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PIK3AP1 ABCC4 NEBL FAT3 LRRK2 DNAH7 MAGI2 RHEX CCDC198 ADGRL3 | 1.89e-09 | 189 | 161 | 10 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-08 | 179 | 161 | 9 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.03e-08 | 180 | 161 | 9 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-08 | 182 | 161 | 9 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 2.83e-08 | 187 | 161 | 9 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-08 | 189 | 161 | 9 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-08 | 191 | 161 | 9 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.06e-08 | 195 | 161 | 9 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.06e-08 | 195 | 161 | 9 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-07 | 178 | 161 | 8 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-07 | 178 | 161 | 8 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.13e-07 | 180 | 161 | 8 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-07 | 181 | 161 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-07 | 181 | 161 | 8 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.55e-07 | 183 | 161 | 8 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-07 | 183 | 161 | 8 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-07 | 184 | 161 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-07 | 184 | 161 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-07 | 184 | 161 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-07 | 184 | 161 | 8 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.85e-07 | 185 | 161 | 8 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-07 | 186 | 161 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.18e-07 | 187 | 161 | 8 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-07 | 187 | 161 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.18e-07 | 187 | 161 | 8 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-07 | 187 | 161 | 8 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-07 | 188 | 161 | 8 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-07 | 189 | 161 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-07 | 189 | 161 | 8 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-07 | 190 | 161 | 8 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-07 | 191 | 161 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.11e-07 | 192 | 161 | 8 | e33579a20ca86dcaf02c97273681ba5eee7561b8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-07 | 196 | 161 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.20e-07 | 197 | 161 | 8 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.74e-07 | 142 | 161 | 7 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.74e-07 | 142 | 161 | 7 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 153 | 161 | 7 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-06 | 161 | 161 | 7 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 164 | 161 | 7 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-06 | 166 | 161 | 7 | 0590e404f45afce90e20f93f90a3def83949c66b | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-06 | 168 | 161 | 7 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 172 | 161 | 7 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 172 | 161 | 7 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 172 | 161 | 7 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 175 | 161 | 7 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 176 | 161 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.94e-06 | 178 | 161 | 7 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 4.08e-06 | 179 | 161 | 7 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-06 | 181 | 161 | 7 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-06 | 181 | 161 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.39e-06 | 181 | 161 | 7 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 182 | 161 | 7 | 2ef6889321fd0104d277518d130e19143b3af41c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-06 | 182 | 161 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 182 | 161 | 7 | 75608f80fd570da499891dc02f8649d5428b896c | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.56e-06 | 182 | 161 | 7 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-06 | 183 | 161 | 7 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-06 | 183 | 161 | 7 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-06 | 183 | 161 | 7 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.90e-06 | 184 | 161 | 7 | 315bb14e848d8e8e4533122047df6f9b89b89d99 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-06 | 185 | 161 | 7 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-06 | 186 | 161 | 7 | 3dae539cce15fcf2b1b32e981d7febe94c03c600 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-06 | 186 | 161 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-06 | 186 | 161 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 161 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 188 | 161 | 7 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 188 | 161 | 7 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-06 | 189 | 161 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-06 | 189 | 161 | 7 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 5.84e-06 | 189 | 161 | 7 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 6.04e-06 | 190 | 161 | 7 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-06 | 190 | 161 | 7 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-06 | 190 | 161 | 7 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.04e-06 | 190 | 161 | 7 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-06 | 190 | 161 | 7 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-06 | 191 | 161 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-06 | 191 | 161 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.25e-06 | 191 | 161 | 7 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 6.47e-06 | 192 | 161 | 7 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | Healthy_donor-B_intermediate|World / disease group, cell group and cell class (v2) | 6.47e-06 | 192 | 161 | 7 | f77007b284e11f8654ad599eef929df7c6c4ebf0 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.69e-06 | 193 | 161 | 7 | a260d943e9db966e4ce7d642313fd11354c2d2ba | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-06 | 193 | 161 | 7 | 9f798a1bbd9f076c3122d02ed28418c18bb7a369 | |
| ToppCell | severe-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.16e-06 | 195 | 161 | 7 | 73e39005a597e13aea571ae6ae5824d1c7448b71 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-06 | 195 | 161 | 7 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-06 | 195 | 161 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.40e-06 | 196 | 161 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-06 | 196 | 161 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-06 | 196 | 161 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.40e-06 | 196 | 161 | 7 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-06 | 197 | 161 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | myeloid-Monocyte|myeloid / Lineage, cell class and subclass | 7.65e-06 | 197 | 161 | 7 | 6acf059cee6ba6bdeacc089b090d72336790972a | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 7.65e-06 | 197 | 161 | 7 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 7.65e-06 | 197 | 161 | 7 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.91e-06 | 198 | 161 | 7 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 198 | 161 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.91e-06 | 198 | 161 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 199 | 161 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | severe-B_memory|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.17e-06 | 199 | 161 | 7 | 6d3436dd65d525aaa23ec02672005380f21c4d0f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.45e-06 | 200 | 161 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| Drug | 8-amino-cADPR | 7.09e-07 | 11 | 158 | 4 | CID003081323 | |
| Drug | 2,4-dichlorophenoxyacetic acid | 4.00e-06 | 132 | 158 | 8 | CID000001486 | |
| Drug | homoarginine hydrochloride | 6.54e-06 | 66 | 158 | 6 | CID000003625 | |
| Drug | Calcium | CYP1A1 TRPV1 PDGFB OGDH RYR1 RYR3 ITPR3 CFD GCLC ADGRL2 SEC61A1 KLK1 NOS1 ALPP | 9.24e-06 | 493 | 158 | 14 | ctd:D002118 |
| Drug | raloxifene hydrochloride; Down 200; 0.1uM; HL60; HG-U133A | 1.04e-05 | 198 | 158 | 9 | 388_DN | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.12e-05 | 7 | 158 | 3 | CID009547999 | |
| Drug | pivaloylcarnitine | 1.12e-05 | 7 | 158 | 3 | CID000126894 | |
| Drug | Br2BAPTA | 1.12e-05 | 7 | 158 | 3 | CID003081001 | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.13e-05 | 200 | 158 | 9 | 3682_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A | 1.13e-05 | 200 | 158 | 9 | 5750_DN | |
| Drug | T0702 | 2.52e-05 | 25 | 158 | 4 | CID000005908 | |
| Drug | PD138142-15 | 2.67e-05 | 9 | 158 | 3 | CID003025787 | |
| Drug | vinyl sulfone | 3.02e-05 | 52 | 158 | 5 | CID000006496 | |
| Drug | Asp-Lys | 3.46e-05 | 27 | 158 | 4 | CID000165361 | |
| Drug | MUGB | 3.80e-05 | 10 | 158 | 3 | CID000134454 | |
| Drug | PCB 95 | 3.80e-05 | 10 | 158 | 3 | CID000038012 | |
| Drug | caged InsP3 | 4.63e-05 | 29 | 158 | 4 | CID000122248 | |
| Drug | BAPNA | 4.73e-05 | 57 | 158 | 5 | CID000013494 | |
| Drug | (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium | 4.79e-05 | 2 | 158 | 2 | DB02648 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 4.79e-05 | 2 | 158 | 2 | ctd:C005147 | |
| Drug | R 478 | 5.19e-05 | 11 | 158 | 3 | CID000084223 | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 6.28e-05 | 193 | 158 | 8 | 2764_UP | |
| Drug | borate | 6.32e-05 | 98 | 158 | 6 | CID000007628 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HG-U133A | 6.51e-05 | 194 | 158 | 8 | 428_DN | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 6.51e-05 | 194 | 158 | 8 | 7189_UP | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 6.51e-05 | 194 | 158 | 8 | 828_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 6.51e-05 | 194 | 158 | 8 | 4291_DN | |
| Drug | 2-aminoethoxydiphenyl borate | 6.57e-05 | 61 | 158 | 5 | ctd:C109986 | |
| Drug | Celecoxib | GABRB2 RALGAPA1 NRG1 ABCC4 GRIN2A ADAR SLC45A4 ABHD4 JAK1 PNCK EPHA8 | 6.65e-05 | 376 | 158 | 11 | ctd:D000068579 |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; HL60; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 6159_UP | |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; HL60; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 3116_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 6692_DN | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 3891_UP | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 5013_DN | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 2760_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 1544_UP | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 3482_UP | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 7363_DN | |
| Drug | benzamidine | 7.66e-05 | 147 | 158 | 7 | CID000002332 | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HG-U133A | 7.78e-05 | 199 | 158 | 8 | 426_UP | |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 4799_DN | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 2402_DN | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 8.05e-05 | 200 | 158 | 8 | 6612_DN | |
| Drug | BAEE | 8.28e-05 | 64 | 158 | 5 | CID000123880 | |
| Drug | C13932 | 9.89e-05 | 206 | 158 | 8 | CID000168297 | |
| Drug | NP-EGTA | 1.13e-04 | 14 | 158 | 3 | CID000183793 | |
| Drug | sodium glycocholate | 1.19e-04 | 69 | 158 | 5 | CID000000755 | |
| Drug | mag-fura-2 | 1.23e-04 | 37 | 158 | 4 | CID000123839 | |
| Drug | AC1L98DX | 1.37e-04 | 38 | 158 | 4 | CID000439957 | |
| Drug | Gvapspat amide | 1.40e-04 | 15 | 158 | 3 | CID000125015 | |
| Drug | cis-diammineplatinum(II | 1.43e-04 | 3 | 158 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.43e-04 | 3 | 158 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 1.43e-04 | 3 | 158 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.43e-04 | 3 | 158 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 1.43e-04 | 3 | 158 | 2 | CID000093551 | |
| Drug | iodipamide ethyl ester | 1.43e-04 | 3 | 158 | 2 | CID000127535 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.43e-04 | 3 | 158 | 2 | CID000080262 | |
| Drug | flubendiamide | 1.43e-04 | 3 | 158 | 2 | CID011193251 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.43e-04 | 3 | 158 | 2 | CID005748312 | |
| Drug | 3-keto-4-pentenoyl-CoA | 1.43e-04 | 3 | 158 | 2 | CID000157435 | |
| Drug | phenytoin | 1.51e-04 | 219 | 158 | 8 | CID000001775 | |
| Drug | NAADP | 1.52e-04 | 39 | 158 | 4 | CID000123952 | |
| Disease | myocardial infarction (is_implicated_in) | 1.38e-05 | 99 | 154 | 6 | DOID:5844 (is_implicated_in) | |
| Disease | ACUTE ALCOHOL WITHDRAWAL | 2.71e-05 | 2 | 154 | 2 | C0149821 | |
| Disease | Hydrocephalus | 8.09e-05 | 3 | 154 | 2 | cv:C0020255 | |
| Disease | Congenital hydrocephalus | 8.09e-05 | 3 | 154 | 2 | cv:C0020256 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.18e-04 | 91 | 154 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | Depressive disorder | 1.46e-04 | 289 | 154 | 8 | C0011581 | |
| Disease | peripheral arterial disease | 1.84e-04 | 54 | 154 | 4 | EFO_0004265 | |
| Disease | chronic kidney disease | 2.45e-04 | 235 | 154 | 7 | EFO_0003884 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology) | 2.68e-04 | 5 | 154 | 2 | DOID:0050431 (implicated_via_orthology) | |
| Disease | clubfoot (is_implicated_in) | 2.68e-04 | 5 | 154 | 2 | DOID:11836 (is_implicated_in) | |
| Disease | desmocollin-2 measurement | 2.68e-04 | 5 | 154 | 2 | EFO_0021936 | |
| Disease | Ischemic stroke | 3.16e-04 | 324 | 154 | 8 | HP_0002140 | |
| Disease | cystic fibrosis (is_implicated_in) | 3.72e-04 | 27 | 154 | 3 | DOID:1485 (is_implicated_in) | |
| Disease | Mental Depression | 3.91e-04 | 254 | 154 | 7 | C0011570 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 4.00e-04 | 6 | 154 | 2 | C1854678 | |
| Disease | portal hypertension (is_marker_for) | 4.00e-04 | 6 | 154 | 2 | DOID:10762 (is_marker_for) | |
| Disease | hydrocephalus (is_implicated_in) | 4.00e-04 | 6 | 154 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 4.57e-04 | 525 | 154 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.57e-04 | 525 | 154 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 4.70e-04 | 527 | 154 | 10 | C1458155 | |
| Disease | caudate nucleus volume | 5.10e-04 | 30 | 154 | 3 | EFO_0004830 | |
| Disease | Alcoholic Intoxication, Chronic | 5.39e-04 | 268 | 154 | 7 | C0001973 | |
| Disease | Breast Carcinoma | 5.52e-04 | 538 | 154 | 10 | C0678222 | |
| Disease | Morphine Abuse | 5.59e-04 | 7 | 154 | 2 | C0600272 | |
| Disease | Morphine Dependence | 5.59e-04 | 7 | 154 | 2 | C0026552 | |
| Disease | internet addiction disorder | 6.78e-04 | 33 | 154 | 3 | EFO_0803368 | |
| Disease | Parkinson's disease (is_implicated_in) | 6.84e-04 | 76 | 154 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | E3 ubiquitin-protein ligase RNF13 measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0801556 | |
| Disease | allantoin measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0010456 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 8.29e-04 | 80 | 154 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Bipolar Disorder | 9.39e-04 | 477 | 154 | 9 | C0005586 | |
| Disease | thiamine measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0010540 | |
| Disease | theophylline measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0021180 | |
| Disease | Chronic Kidney Diseases | 1.18e-03 | 10 | 154 | 2 | C1561643 | |
| Disease | end stage renal disease (is_implicated_in) | 1.28e-03 | 41 | 154 | 3 | DOID:783 (is_implicated_in) | |
| Disease | bitter beverage consumption measurement | 1.38e-03 | 42 | 154 | 3 | EFO_0010089 | |
| Disease | beta-nerve growth factor measurement | 1.38e-03 | 42 | 154 | 3 | EFO_0008035 | |
| Disease | glycerophosphorylcholine measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0020018 | |
| Disease | bronchopulmonary dysplasia | 1.68e-03 | 45 | 154 | 3 | MONDO_0019091 | |
| Disease | hydroxy-leucine measurement | 1.68e-03 | 45 | 154 | 3 | EFO_0005276 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 1.73e-03 | 12 | 154 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | Congenital myopathy (disorder) | 1.73e-03 | 12 | 154 | 2 | C0270960 | |
| Disease | Neurobehavioral Manifestations | 1.73e-03 | 12 | 154 | 2 | C0525041 | |
| Disease | interleukin 6 receptor subunit alpha measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0008187 | |
| Disease | cirrhosis of liver | 2.03e-03 | 13 | 154 | 2 | EFO_0001422 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0802114 | |
| Disease | depressive symptom measurement, stressful life event measurement | 2.28e-03 | 50 | 154 | 3 | EFO_0007006, EFO_0007781 | |
| Disease | Yu-Zhi constitution type | 2.72e-03 | 15 | 154 | 2 | EFO_0007638 | |
| Disease | mean platelet volume | HDAC9 NRF1 NUP210L LRRK2 SULT1C4 LRCH1 SLC45A4 SCD CPEB4 DOCK7 KLHL8 PRDM16 DSE | 2.75e-03 | 1020 | 154 | 13 | EFO_0004584 |
| Disease | Acute Cerebrovascular Accidents | 2.85e-03 | 54 | 154 | 3 | C0751956 | |
| Disease | neuroticism measurement, cognitive function measurement | 3.00e-03 | 566 | 154 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | Polyposis, Adenomatous Intestinal | 3.10e-03 | 16 | 154 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 3.10e-03 | 16 | 154 | 2 | C2713443 | |
| Disease | serum gamma-glutamyl transferase measurement | ENTPD7 PIK3AP1 NUP210L MCC KLF15 FCGR2B GCLC ULK1 KLHL8 ARHGEF2 ADGRL2 CDH6 | 3.14e-03 | 914 | 154 | 12 | EFO_0004532 |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 3.50e-03 | 17 | 154 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | Adenomatous Polyposis Coli | 3.50e-03 | 17 | 154 | 2 | C0032580 | |
| Disease | serum urea measurement | 3.66e-03 | 195 | 154 | 5 | EFO_0009795 | |
| Disease | serum metabolite measurement | RALGAPA1 CYP1A1 ABCC4 CRAT SLC45A4 MAGI2 NWD2 ALMS1 DOCK7 SLC28A1 NPRL3 MDGA1 | 4.10e-03 | 945 | 154 | 12 | EFO_0005653 |
| Disease | Cerebrovascular accident | 4.21e-03 | 62 | 154 | 3 | C0038454 | |
| Disease | Malignant neoplasm of breast | CYP1A1 NRG1 FLNB COL7A1 DSC3 TRMT11 MANEA ADAR PER3 HEY1 N4BP2 SLC28A1 VEGFB | 4.25e-03 | 1074 | 154 | 13 | C0006142 |
| Disease | blood metabolite measurement | 4.37e-03 | 19 | 154 | 2 | EFO_0005664 | |
| Disease | dense area measurement, mammographic density measurement | 4.37e-03 | 19 | 154 | 2 | EFO_0005941, EFO_0006503 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLDKDVSMYPSSVRH | 6 | Q99626 | |
| MTDAGRPHSEAAYTL | 766 | Q9BZ76 | |
| GSLYPEMSAHERSLD | 686 | Q14203 | |
| LATEPHVRMVTLYDN | 296 | Q9ULA0 | |
| HYDMETTELPELTST | 406 | P10323 | |
| PEMYEVHTASRDDRS | 546 | Q92974 | |
| AENTITYSLLMHPDA | 286 | P31994 | |
| TPAEITKHSMDLSYA | 221 | Q9Y312 | |
| EDLQSPHRDSLYTSM | 1346 | Q9HAR2 | |
| KPTRESEYHSSDLRM | 446 | Q8TCU4 | |
| PDSYVRDMEIKGASH | 306 | Q8TB40 | |
| DHLQSPNRDSLYTSM | 1361 | O95490 | |
| TMPRVSEDVYRSHVA | 291 | P43155 | |
| DEYELLMPHRISSHF | 146 | Q8N6F7 | |
| YRVMAVDALASSHPL | 441 | P15144 | |
| DMDSCLSRHSINPYS | 231 | O76075 | |
| DAVYESMAHLSTDLL | 416 | Q6ZUJ8 | |
| TSHPYILADRMEDLT | 251 | Q14692 | |
| DEPDTMHTRLKYSII | 271 | Q02487 | |
| VPLHSSMDVTYSPER | 946 | Q9ULI1 | |
| LMHLVVESFPSYRDV | 181 | Q5T6V5 | |
| DRSHLPYMEAFILET | 361 | P04798 | |
| LHELLTYCDSDSSPM | 1071 | P23458 | |
| VPMAAHEASSLYSEE | 361 | Q9H3S7 | |
| VEDHSPLMYHISLVD | 1356 | Q14573 | |
| RDSPHSERYVSAMTT | 416 | Q02297 | |
| APTHSDYTMTLLDLF | 391 | Q9UGN5 | |
| EAEAHARPYMASVQL | 31 | P00746 | |
| DMASRIIHYTEPINS | 731 | Q8NFP4 | |
| RILPHTVLYMADSET | 96 | Q8NEZ5 | |
| IAYAHSTIMPRLSEE | 691 | P33991 | |
| RMDSSGPDYKELDVH | 766 | Q86UL8 | |
| DYSHDLMLLRLTEPA | 116 | P06870 | |
| VYSSHSMGARVDLEP | 751 | Q9HCH0 | |
| AMADTPEHASDYLRP | 136 | Q9NQZ7 | |
| VLRHSNYTLPLEESM | 161 | Q9NU53 | |
| ETMSHYTDEPRFTIE | 11 | Q6NT76 | |
| VSITSAHIDPDASYM | 171 | Q9BVC4 | |
| IHPDVDEHSVMTYLS | 221 | O75369 | |
| PEELYEMLSDHSIRS | 26 | P01127 | |
| SSRLHSYVKAEEDPM | 4101 | Q9Y6V0 | |
| SMYSLEELATIASEH | 111 | P56645 | |
| SILSYLHPEDRSLMV | 306 | P56645 | |
| DPESSAMLDYELHSD | 206 | O75051 | |
| MASLSSVERYDPHLD | 471 | Q9P2G9 | |
| LHTYVCLMASPSEEE | 406 | Q12980 | |
| EASRASKPDHIYMDA | 226 | P48506 | |
| TYTEHSMLSADEDSP | 31 | Q16656 | |
| HVYSLSEPEMAALRD | 546 | Q86TG7 | |
| LSHMDVSRYVSPEQK | 241 | P0DUQ1 | |
| TADSLYLHTMERPHL | 296 | Q9Y2L9 | |
| PHLRSLDMSSNDIQY | 1196 | Q5S007 | |
| LTEAVHTMLSSPLEY | 71 | Q9UL01 | |
| YTMDPHENILLSTLE | 396 | P47870 | |
| LLHAMVAYDPDERIA | 261 | Q9UQ07 | |
| LDLLYDTLDMEHPSD | 286 | Q86VP3 | |
| VEMHPAYTEEELRRF | 336 | Q02818 | |
| YSSRDPSVIETHMRQ | 161 | Q5SRI9 | |
| EVRSTSHKPDEIYGM | 506 | Q86U44 | |
| SISSSPDMYPDEVHL | 1181 | P29475 | |
| TAAEYMLSDALLPDR | 6 | Q96QZ0 | |
| LEDVHESPSHLYLAM | 76 | Q6P2M8 | |
| IPVTDHTYEDCRLMI | 316 | Q7L5N7 | |
| EDDMYSVLPEDRSQH | 41 | O15439 | |
| MKYEIHRDSTLDPSL | 296 | P05187 | |
| GDMKYEIHRDSTLDP | 291 | P10696 | |
| SLLRHPEARSSFDEM | 861 | Q02218 | |
| TMLELESIHIDPLSY | 586 | P23508 | |
| VMSYSEDHRSLLAPE | 121 | Q8WZ55 | |
| AYLRSEIMSLHEASE | 326 | Q8NCX0 | |
| ESEMDPHVRDCIRSY | 106 | Q96N67 | |
| DEPDTMHTRLKYSIL | 271 | Q14574 | |
| CSDRAMESTESRHYP | 976 | P55265 | |
| AVPSSAELHYMAASV | 2626 | Q9H799 | |
| KLRASTVMYHPEGES | 146 | O95999 | |
| HSEERDTPKMYCSAE | 236 | P29322 | |
| HLAELEPSSLYEVLM | 641 | Q4KMG0 | |
| MKESVAPTEHLRLYD | 481 | Q8WXX0 | |
| YSLHSDSQPEKVMEA | 2851 | Q8TDW7 | |
| RYAHPTDASMIEASD | 196 | Q9NUK0 | |
| TESPKVRDMYATHLA | 426 | Q9Y2E5 | |
| MAIDRYLATVHPISS | 206 | Q99705 | |
| PGEAYSRMSHALEEI | 141 | Q5VWX1 | |
| AYHMLPSPVSEDDSD | 31 | Q9UIH9 | |
| MKRAHPEYSSSDSEL | 1 | Q9Y5J3 | |
| PVKYSVDRHTDMDRI | 416 | P55285 | |
| TAVVTAHRYMLAPDA | 1136 | Q02388 | |
| DRPRTFDMHSLESSL | 376 | Q17RY0 | |
| PHYLESRVEAFLITM | 856 | P14735 | |
| PRIVRESYAMTSAHE | 6566 | Q8NDH2 | |
| IHEDSMNLLSLYTSP | 311 | Q9UKV0 | |
| VRAMAVLTDHPYASL | 196 | O95865 | |
| LSPHVVSELLDTYMS | 371 | O60645 | |
| SRDMYFDIPLEHRET | 76 | Q9NVL8 | |
| EAVMSTLEHLHVDYP | 21 | Q5GAN4 | |
| LAESGARYTEMPHVI | 3256 | P21817 | |
| MLYTLRVDASNTHPD | 341 | Q9ULB4 | |
| MALSAETESHIYRAL | 1 | O14569 | |
| SSLLVYSMEDSSPHV | 271 | Q9UKG9 | |
| QSMDVLHRTYSAPAI | 241 | Q9H4L5 | |
| TYMEAESSVELVPLH | 941 | Q5VU65 | |
| MDSHRDAIPDYEALV | 1101 | Q9P2P1 | |
| TPAMALADSAIRYDA | 1026 | O14654 | |
| DLIRYAAATHMLSDI | 601 | Q9Y2M0 | |
| ERYVSMPREEAAEHI | 421 | Q6NUM9 | |
| TDPSITHENMDAYLS | 386 | Q9BRS2 | |
| SDYHEERTILPMSRA | 866 | Q93008 | |
| VPVSLSYHLSDMFLD | 341 | Q7Z4G4 | |
| DIPMSDSLYRHDSDT | 76 | Q6ZWK4 | |
| DTSMVHELNRYIPTA | 406 | Q9H9S3 | |
| HRSSSPELSEMLEYD | 1146 | P12259 | |
| PELSEMLEYDRSHKS | 1151 | P12259 | |
| MWLADRHSDPELYTA | 151 | Q9NVX7 | |
| MYEPNRDLLASHSAE | 21 | Q9HAZ2 | |
| RNPYMPETSDSLHEV | 291 | Q9NXP7 | |
| LSHMDVSRYVSPEQK | 241 | A6NGN4 | |
| VELTPDYSMESHQRD | 456 | Q96HU1 | |
| MTTEVILHYRPCESD | 1 | Q6ZNX1 | |
| PSTSLGELEHYDLDM | 136 | Q9Y6H5 | |
| MAPEDHYRRLVSALS | 186 | Q96NU1 | |
| LSHMDVSRYVSPEQK | 241 | A3QJZ7 | |
| SRDSPLKTLMSHYEE | 366 | Q8NCF5 | |
| PSSSYASDHDMIVSI | 301 | Q8NGG2 | |
| LSDEAPHMLVVYSAN | 131 | Q9BXB5 | |
| KMDAEHPELRSYAQS | 196 | Q12765 | |
| YVESDSRLHLESMLL | 191 | Q9BW66 | |
| HELALDYPDVDIMRS | 291 | Q5BKX6 | |
| MYEPSELESSHLTDQ | 271 | Q7KZ85 | |
| LSHMDVSRYVSPEQK | 241 | O60810 | |
| HLLPSTEASSYEMDK | 1371 | Q6GYQ0 | |
| LASVDYDPFMHLESL | 1456 | Q6GYQ0 | |
| DPVLDLHMSLEELYT | 891 | O75970 | |
| AYSSSETPNRHDMLL | 401 | Q8NER1 | |
| ETSMVHELNRYIPTA | 406 | P61619 | |
| EDDDSHPSEMRLYKN | 96 | Q9GZP4 | |
| DLAESGARYTEMPHV | 3116 | Q15413 | |
| PSMRATYLSVADEHL | 511 | Q9BSA4 | |
| LSHMDVSRYVSPEQK | 241 | P0DUQ2 | |
| HLLAESYSAVMELTR | 821 | O94964 | |
| NYSSIPAEIMDHSIS | 246 | O75897 | |
| THPEESMYKRLGVSA | 386 | Q8TBP0 | |
| VPRSRAEMYDDVHSD | 46 | Q8IX01 | |
| SSYHVSMDLLEDPTS | 686 | Q99250 | |
| SLDTLPGYEEALHMS | 131 | Q4KMG9 | |
| ATHYPTDERKLLSMT | 391 | Q9H5I5 | |
| LISLATDDHTMYAAV | 1381 | Q6ZS81 | |
| LSHMDVSRYVSPEQK | 241 | O60813 | |
| MPAHLLQDDISSSYT | 1 | O00767 | |
| IRPYLADMTLSEVHV | 326 | O00337 | |
| YPSSQLGEMSLEEHS | 106 | P49765 | |
| SILSDGVYERHMDPL | 146 | Q8TBC5 | |
| MEDPKSSDIQLYHSE | 681 | O43314 | |
| MYSLLLDFVPTDSHR | 86 | O60806 | |
| RERIYHVDDTPSGSM | 476 | Q9P2L0 | |
| ADYLHAMRTLSEDTI | 101 | O75385 | |
| PFVLSLMSEEHTAVY | 926 | Q562E7 | |
| THTEMERSRVAPGEY | 381 | Q6PEW1 | |
| ESHYPDVFMREALAL | 126 | A6NJT0 | |
| TPLHVAEYMLDAARN | 531 | P35573 | |
| PDYDAASHDQDIMLL | 96 | Q92876 | |
| LSIEEFRDYVLHMPT | 841 | Q5T7N2 | |
| LILETPHMYFSDSES | 676 | Q86UW6 | |
| YLPEEMAHSDISETS | 1051 | Q12879 | |
| HTYSAELDRPDIKMA | 171 | O76041 | |
| RQHPDTLKYSTLMDS | 1961 | P20929 | |
| YDPAEDNIQSRSLHM | 6511 | P20929 | |
| EASSISHMPQLIDIY | 251 | P16519 |